Japanese pharma outsources earlier as peptide development challenges grow
Study suggests phospholipid therapy may impact fatty liver disease outcomes
FDA signals support for development of psychedelic therapies in mental healthmental health
New web series explores path from ophthalmic research to patient access
EMA backs plozasiran for rare lipid disorder with high pancreatitis risk